Metropolitan Life Insurance Company (MetLife)’s Sonder SOND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-574
Closed -$8.69K 2511
2023
Q1
$8.69K Sell
574
-69
-11% -$1.6K ﹤0.01% 2204
2022
Q4
$15.9K Hold
643
﹤0.01% 2113
2022
Q3
$21.3K Buy
+643
New +$21.4K ﹤0.01% 1998

Other funds holding SOND

Metropolitan Life Insurance Company (MetLife)'s SOND Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sonder (SOND) in Q2 2023, closing a stake of 574 shares — an estimated $8.69K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SOND in Q3 2022 and held it in 3 quarters. The position peaked at $21.3K in Q3 2022. 82 funds tracked by Wall St. Rank hold SOND as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sonder position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 574 Sonder shares in Q2 2023, an estimated $8.69K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sonder in Q3 2022 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sonder position peaked at $21.3K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Sonder as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.